SC 13D

Company

Elicio Therapeutics, Inc.

Filed

April 27, 2022

Accession Number

0001601485-22-000030

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →